Anavex Life Sciences Corp (AVXL)

[Gator328]

If A-273 is only marginally better than the placebo, as some are indicating based on the lack of data in yesterday's press release, why would Dr. Missling submit it for peer review and want to announce the data at a major science conference?

They'd be laughed at by their colleagues for basically going on stage and saying that A273 is just a little better than doing nothing at all.

That's the sort of data you put in a PR, accept whatever the stock market thinks, and push forward silently toward P3. You don't make a big deal of it. But it seems that Missling intends to make a big deal of this data.

To me, that seems like it's at least halfway decent. Read between the lines. Always.